![]() |
|
|
Forward to a colleague |
||
Access Full Stories Paraytec has been chosen to lead a £1m (€1.4m) consortium project to develop new analytical instruments that will detect aggregation in biopharmaceutical processing... Read Bruker buys Bruker in cash and stock deal Bruker BioSciences is to acquire the affiliated, but privately-held Bruker BioSpin group for $914m (€620m) in a bid to expand its distribution capabilities and increase its customer base... Read Exiqon enters cancer diagnostic field with Oncotech acquisition Gene expression analysis expert Exiqon is to pay up to $45m (€30.7m) for diagnostics company Oncotech as a first step towards becoming a world leading miRNA diagnostic manufacturer... Read Asylum Research in the dock over Veeco's patent claims Veeco's patent infringement case against Asylum Research is set to go to court after a US Court ruled that three of Veeco's atomic force microscopy (AFM) patents were potentially being breached... Read 'Technology Pioneers' elected to World Economic Forum The World Economic Forum has announced this year's 'Technology Pioneers', firms which have developed a life-changing technology innovation that has the potential for long-term impact on both business and society... Read |
||||||||||||||||||
All News Headlines for: December | November | October |
||||||||||||||||||
ZIC®-HILIC Separation of Polar and Hydrophilic Compounds SeQuant is introducing a new ZIC®-HILIC column for ultra-high speed applications. Its potential is illustrated by a complete baseline separation of Oseltamavir (Tamiflu®) from Oseltamavir Carboxylate followed by MS/MS detection in less than 40 seconds... Click Here | ||||||||||||||||||
|
Related Industry News Medgenics gets (bio)pumping Medgenics' Biopump could be the solution to the issues surrounding protein therapy and is set to take on the $51bn US biopharmaceutical market after raising £3.28m ($6.76m) in funding in its Initial Public... Read Covance divests cardiac unit Covance has announced the $35m sale of its electrocardiogram (ECG) unit in order to focus on its core businesses... Read Addex and Merck target new cure for Parkinson's Merck & Co. has entered into an exclusive collaboration and licensing deal with Addex Pharma to develop a new class of orally available Parkinson's therapies... Read India's Glenmark pioneering through prioritising preclinical Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||